Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to -$5.6 billion.

  • Genmab A's Cash from Investing Activities fell 28507.26% to -$5.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.6 billion, marking a year-over-year decrease of 9418.44%. This contributed to the annual value of -$5.6 billion for FY2025, which is 28997.93% down from last year.
  • As of Q4 2025, Genmab A's Cash from Investing Activities stood at -$5.6 billion, which was down 28507.26% from -$54.0 million recorded in Q3 2025.
  • In the past 5 years, Genmab A's Cash from Investing Activities ranged from a high of $26.0 million in Q2 2025 and a low of -$5.6 billion during Q4 2025
  • For the 3-year period, Genmab A's Cash from Investing Activities averaged around -$970.4 million, with its median value being -$185.0 million (2023).
  • In the last 5 years, Genmab A's Cash from Investing Activities tumbled by 68216.22% in 2024 and then surged by 10204.72% in 2025.
  • Genmab A's Cash from Investing Activities (Quarter) stood at -$185.0 million in 2023, then tumbled by 682.16% to -$1.4 billion in 2024, then crashed by 285.07% to -$5.6 billion in 2025.
  • Its Cash from Investing Activities was -$5.6 billion in Q4 2025, compared to -$54.0 million in Q3 2025 and $26.0 million in Q2 2025.